A comprehensive view of Eli Lilly & Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and plaintiffs abandon proposed US$13.5M settlement regarding alleged overpricing of insulin; the move follows a court ruling against certifying specific state-classes in the case
Published: April 17, 2024 by FiercePharma
GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published: April 17, 2024 by GlobalData Plc
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "PEPTIDES FOR INCRETIN SYNTHESIS"
Published: April 17, 2024 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "METHODS OF TREATING FATIGUE IN ULCERATIVE COLITIS"
Published: April 17, 2024 by U.S. Fed News
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "GENE THERAPY FOR TREM2-ASSOCIATED DISEASES AND DISORDERS"
Published: April 17, 2024 by U.S. Fed News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count